Suffern, NY, United States of America

Raymond J Krasinski

USPTO Granted Patents = 13 

Average Co-Inventor Count = 2.4

ph-index = 7

Forward Citations = 1,292(Granted Patents)


Company Filing History:


Years Active: 1999-2021

Loading Chart...
13 patents (USPTO):Explore Patents

Title: Innovations of Raymond J Krasinski

Introduction

Raymond J Krasinski is a notable inventor based in Suffern, NY (US), recognized for his contributions to the field of genomic data security and analysis. With a total of 13 patents to his name, he has made significant strides in developing methods that enhance the protection and transmission of sensitive genetic information.

Latest Patents

Among his latest patents is the invention titled "Proactive resistance to re-identification of genomic data." This method assesses the risk associated with requests for allele frequency from a genetic database. The process involves generating an allele database, an inquirer database, and calculating risk scores to evaluate the safety of the request. Another significant patent is "Secure transmission of genomic data," which addresses the need for efficient and secure methods to transmit genomic data. This invention discusses novel techniques for encoding and encrypting processed variant information, ensuring that sensitive data is transmitted covertly and securely.

Career Highlights

Krasinski has worked with prominent companies such as Koninklijke Philips Corporation N.V. and Philips Electronics North America Corporation. His experience in these organizations has contributed to his expertise in the field of genomic data and security.

Collaborations

Throughout his career, Krasinski has collaborated with notable individuals, including Michael A Epstein and Ying Huang. These partnerships have likely enriched his work and led to innovative solutions in his field.

Conclusion

Raymond J Krasinski's work in genomic data security and transmission showcases his innovative spirit and dedication to advancing technology in this critical area. His patents reflect a commitment to enhancing the safety and efficiency of handling sensitive genetic information.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…